U.S. Markets close in 5 hrs 18 mins

Today's Research Reports on ESSA Pharma, Medicure, Aphria and OrganiGram

NEW YORK, NY / ACCESSWIRE / December 6, 2018 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.

The Market Edge Initiates Coverage on:

ESSA Pharma Inc.
https://marketedgereport.com/report/EPI.V/

Medicure Inc.
https://marketedgereport.com/report/MPH.V/

Aphria Inc.
https://marketedgereport.com/report/APHA.TO/

OrganiGram Holdings Inc.
https://marketedgereport.com/report/OGI.V/

ESSA Pharma's stock had no change Wednesday, to close the day at $3.80. The stock recorded a trading volume of 1,470 shares, which was above its three months average volume of 850 shares. In the last year, ESSA Pharma's shares have traded in a range of 3.00 - 7.15. The share price has gained 26.67% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.05 is lower than its 200-day moving average of $4.40. Shares of ESSA Pharma have fallen approximately 29.63 percent year-to-date.

Access The Market Edge's ESSA Pharma Inc. Research Report:
https://marketedgereport.com/report/EPI.V/

On Wednesday, shares of Medicure recorded a trading volume of 1,000 shares, which was below the three months average volume of 6,410 shares. The stock ended the day 0.32% higher at $6.18. The share price has fallen 22.46% from its 52 week high with a 52 week trading range of 5.56 - 7.97. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.43 is lower than its 200-day moving average of $6.87. Shares of the company are trading at a Price to Earnings ratio of 2.07. Shares of Medicure have fallen approximately 17.05 percent year-to-date.

Access The Market Edge's Medicure Inc. Research Report:
https://marketedgereport.com/report/MPH.V/

Aphria's stock moved 16.53% lower Wednesday, to close the day at $5.00. The stock recorded a trading volume of 30,308,849 shares, which was above its three months average volume of 7,789,759 shares. In the last year, Aphria's shares have traded in a range of 4.76 - 17.60. The share price has gained 5.04% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $12.74 is lower than its 200-day moving average of $12.74. Shares of the company are trading at a Price to Earnings ratio of 25.91. Shares of Aphria have approximately 0 percent year-to-date.

Access The Market Edge's Aphria Inc. Research Report:
https://marketedgereport.com/report/APHA.TO/

On Wednesday, shares of OrganiGram Holdings recorded a trading volume of 1,373,663 shares, which was below the three months average volume of 1,803,043 shares. The stock ended the day 12.22% lower at $4.31. The share price has fallen 49.59% from its 52 week high with a 52 week trading range of 2.75 - 8.55. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $7.04 is greater than its 200-day moving average of $5.44. Shares of the company are trading at a Price to Earnings ratio of 1436.67. Shares of OrganiGram Holdings have gained approximately 5.12 percent year-to-date.

Access The Market Edge's OrganiGram Holdings Inc. Research Report:
https://marketedgereport.com/report/OGI.V/

Our Actionable Research on ESSA Pharma Inc. (TSXV:EPI.V), Medicure Inc. (TSXV:MPH.V), Aphria Inc. (TSX:APHA.TO) and OrganiGram Holdings Inc. (TSXV:OGI.V) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: MarketEdgeReport